Determinants of cutaneous injection-related infection care at a supervised injecting facility.

[1]  J. Montaner,et al.  Nurse-delivered safer injection education among a cohort of injection drug users: evidence from the evaluation of Vancouver's supervised injection facility. , 2008, The International journal on drug policy.

[2]  L. Topp,et al.  Prevalence and predictors of injecting‐related injury and disease among clients of Australia's needle and syringe programs , 2008, Australian and New Zealand journal of public health.

[3]  Rachel A. Smith,et al.  ‘Searching for a “generalized social agent” to predict Namibians’ intentions to prevent sexual transmission of HIV , 2008, AIDS care.

[4]  T. Kerr,et al.  Drug sharing with clients as a risk marker for increased violence and sexual and drug-related harms among survival sex workers , 2008, AIDS care.

[5]  I. Binswanger,et al.  Predictors of Hospitalization for Injection Drug Users Seeking Care for Soft Tissue Infections , 2007, Journal of general internal medicine.

[6]  J. Montaner,et al.  Attendance at supervised injecting facilities and use of detoxification services. , 2006, The New England journal of medicine.

[7]  S. Asch,et al.  Hospital Utilization for Injection Drug Use-Related Soft Tissue Infections in Urban versus Rural Counties in California , 2006, Journal of Urban Health.

[8]  R. Hogg,et al.  Prevalence and correlates of abscesses among a cohort of injection drug users , 2005, Harm reduction journal.

[9]  R. Hogg,et al.  Requiring Help Injecting Independently Predicts Incident HIV Infection Among Injection Drug Users , 2005, Journal of acquired immune deficiency syndromes.

[10]  J. Montaner,et al.  Do supervised injecting facilities attract higher-risk injection drug users? , 2005, American journal of preventive medicine.

[11]  J. Montaner,et al.  Safer injection facility use and syringe sharing in injection drug users , 2005, The Lancet.

[12]  R. Bluthenthal,et al.  Police crackdowns, societal cost, and the need for alternative approaches , 2005 .

[13]  J. Montaner,et al.  Methodology for evaluating Insite: Canada's first medically supervised safer injection facility for injection drug users , 2004, Harm reduction journal.

[14]  J. Montaner,et al.  Rationale for evaluating North America's first medically supervised safer-injecting facility. , 2004, The Lancet. Infectious diseases.

[15]  N. Wright,et al.  Supervised injecting centres , 2004 .

[16]  M. Schechter,et al.  Requiring Help Injecting as a Risk Factor for HIV Infection in , 2003 .

[17]  A. Murr,et al.  The Importance of Etiology on the Clinical Course of Neck Abscesses , 2003, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[18]  J. Kimber,et al.  Drug consumption facilities: an update since 2000. , 2003, Drug and alcohol review.

[19]  R. Heimer,et al.  Expanding harm reduction services through a wound and abscess clinic. , 2002, American journal of public health.

[20]  H. Harris,et al.  Care of injection drug users with soft tissue infections in San Francisco, California. , 2002, Archives of surgery.

[21]  H. Pollack,et al.  The Impact of Needle Exchange–based Health Services on Emergency Department Use , 2002 .

[22]  B. Edlin,et al.  Soft tissue infections among injection drug users--San Francisco, California, 1996-2000. , 2001, MMWR. Morbidity and mortality weekly report.

[23]  M. Schechter,et al.  Hospital utilization and costs in a cohort of injection drug users. , 2001, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[24]  E. Vittinghoff,et al.  Risk factors for skin and soft-tissue abscesses among injection drug users: a case-control study. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  D. McDonald,et al.  Drug consumption facilities in Europe and the establishment of supervised injecting centres in Australia , 2000 .

[26]  K. McGeary,et al.  Chronic illicit drug use, health services utilization and the cost of medical care. , 2000, Social science & medicine.

[27]  R. Hogg,et al.  The social determinants of emergency department and hospital use by injection drug users in Canada , 1999, Journal of urban health.

[28]  S. Darke,et al.  Self-report among injecting drug users: a review. , 1998, Drug and alcohol dependence.

[29]  R. Coutinho,et al.  Human immunodeficiency virus infection and other risk factors for skin abscesses and endocarditis among injection drug users. , 1996, Journal of clinical epidemiology.

[30]  M. Schein,et al.  Soft tissue abscesses associated with parenteral drug abuse: presentation, microbiology, and treatment. , 1995, The American surgeon.

[31]  Nancy Reid,et al.  Influence functions for proportional hazards regression , 1985 .

[32]  A. White.  Medical disorders in drug addicts. 200 consecutive admissions. , 1973, JAMA.

[33]  P. Giudice.  Cutaneous complications of intravenous drug abuse. , 2004 .

[34]  K. Seal,et al.  Prevalence and duration of hepatitis C among injection drug users in San Francisco, Calif. , 2001, American journal of public health.

[35]  L. J. Wei,et al.  Regression analysis of multivariate incomplete failure time data by modeling marginal distributions , 1989 .